Planta Med 2021; 87(15): 1244
DOI: 10.1055/s-0041-1736763
Abstracts
3. Short Lectures

New human urine biomarkers associated with hydroxytyrosol consumption and olive-based products

Theodora Nikou
1   Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, NKUA, Panepistimioupoli Zografou, Athens, Greece
,
Christina Fytili
2   First Department of Propaedeutic and Internal Medicine, Department of Medicine, NKUA, 11527, Athens, Greece
,
Evangelos Kalampokis
1   Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, NKUA, Panepistimioupoli Zografou, Athens, Greece
,
Nikolaos Tentolouris
2   First Department of Propaedeutic and Internal Medicine, Department of Medicine, NKUA, 11527, Athens, Greece
,
Ioulia K. Tseti
3   Uni-Pharma SA, 14th klm National Road 1, Kifissia, 14564, Athens, Greece
,
Leandros A Skaltsounis
1   Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, NKUA, Panepistimioupoli Zografou, Athens, Greece
,
Maria Halabalaki
1   Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, NKUA, Panepistimioupoli Zografou, Athens, Greece
› Author Affiliations
 

Hydroxytyrosol (HT) is one of the most characteristic compound of olive products and a highly potent compound with proven positive impact to human health [1]. Moreover, HT is also an endogenous metabolite produced from dopamine. The release of many HT-based products in the market directed the current research efford to the exploration of HT effect in obesity and investigation of its ADMET properties based on a human intervation study.

Therefore, HT was administered as a soft capsule to 28 obese/overweight women in different doses to investigate its anti-obesity effect and the impact on urine metabolome. Towards this purpose, urine samples were collected in three time points (T=0, T=3 months, T=6 months) and analyzed via UPLC-Orbitrap MS using untargeted metabolomics aiming to biomarkers discovery. The three different groups (control, high and low dose) were discriminated according to the administered capsule and dose and 30 statistically significant metabolites were uncovered. Among them, hippuric acid (HA) and phenylacetylglutamine (PAG), two endogenous urine metabolites were distinguished. Additionally, UHPLC-TQ MS methodology using multipole reaction monitoring (MRM) method was used for HA and PAG quantitation in urine samples. HT and homovanillic acid, the most common metabolic derivative of HT, were also quantified. The proposed biomarkers levels verified our initial findings. HA and PAG were associated for the first time with HT consumption and could be utilised as biomarkers.



Publication History

Article published online:
13 December 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 EFSA. Panel on Dietetic Products N and A (NDA) 9: 1-25 2011;